How does TECVAYLI® work? TECVAYLI ® is the first treatment of its kind for multiple myeloma—it’s called a bispecific antibody , and it works by binding to both multiple myeloma …

All patients treated with TECVAYLI or TALVEY receive a Patient Wallet Card. Patients should carry the Wallet Card to remind them of the signs and symptoms of CRS and neurologic …

Nov 20, 2025 · Tecvayli (teclistamab) is a bispecific monoclonal antibody used to treat adults with relapsed and refractory multiple myeloma. Tecvayli helps slow the progression of multiple …

Oct 23, 2024 · Find patient medical information for Tecvayli (teclistamab-cqyv) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Cytokine release syndrome (CRS), including life-threatening or fatal reactions, can occur in patients receiving TECVAYLI®. Initiate treatment with TECVAYLI® step-up dosing schedule to …

1 day ago · TECVAYLI ® monotherapy demonstrates superior progression-free and overall survival versus standard of care as early as first relapse in patients with multiple myeloma …

Apr 11, 2025 · TECVAYLI is a prescription medicine to treat adults with multiple myeloma who 1: have already received at least 4 treatment regimens, including a proteasome inhibitor, an …

Oct 8, 2025 · Tecvayli is a cancer medicine used to treat adults with multiple myeloma (a cancer of the bone marrow).

What Is Tecvayli? TECVAYLI® (also known as teclistamab-cqyv, the generic drug name), is the first in a drug class of bispecific antibodies approved by the U.S. Food and Drug …

Aug 26, 2025 · TECVAYLI is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a …